Connection

Özlem Türeci to Humans

Back to Details
This is a "connection" page, showing publications Özlem Türeci has written about Humans.
Özlem Türeci
Connection Strength
0.057
Humans
  1. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature. 2021 07; 595(7868):572-577.
    View in: PubMed
    Score: 0.008
  2. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses. Nature. 2020 10; 586(7830):594-599.
    View in: PubMed
    Score: 0.007
  3. Challenges towards the realization of individualized cancer vaccines. Nat Biomed Eng. 2018 08; 2(8):566-569.
    View in: PubMed
    Score: 0.006
  4. A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancer. Eur J Cancer. 2018 09; 100:17-26.
    View in: PubMed
    Score: 0.006
  5. Personalized vaccines for cancer immunotherapy. Science. 2018 Mar 23; 359(6382):1355-1360.
    View in: PubMed
    Score: 0.006
  6. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature. 2017 07 13; 547(7662):222-226.
    View in: PubMed
    Score: 0.006
  7. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med. 2021 07 15; 385(3):239-250.
    View in: PubMed
    Score: 0.002
  8. Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study. Nat Med. 2021 06; 27(6):1062-1070.
    View in: PubMed
    Score: 0.002
  9. BNT162b vaccines protect rhesus macaques from SARS-CoV-2. Nature. 2021 04; 592(7853):283-289.
    View in: PubMed
    Score: 0.002
  10. Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera. Science. 2021 03 12; 371(6534):1152-1153.
    View in: PubMed
    Score: 0.002
  11. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020 12 31; 383(27):2603-2615.
    View in: PubMed
    Score: 0.002
  12. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates. N Engl J Med. 2020 12 17; 383(25):2439-2450.
    View in: PubMed
    Score: 0.002
  13. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 2020 10; 586(7830):589-593.
    View in: PubMed
    Score: 0.002
  14. Personalized Neo-Epitope Vaccines for Cancer Treatment. Recent Results Cancer Res. 2020; 214:153-167.
    View in: PubMed
    Score: 0.002
  15. Improvement of In Vivo Expression of Genes Delivered by Self-Amplifying RNA Using Vaccinia Virus Immune Evasion Proteins. Hum Gene Ther. 2017 12; 28(12):1138-1146.
    View in: PubMed
    Score: 0.001
  16. Elimination of large tumors in mice by mRNA-encoded bispecific antibodies. Nat Med. 2017 Jul; 23(7):815-817.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.